| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/14/2003 | EP0970077B1 Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 05/14/2003 | EP0954521B1 4- (thien-3-yl)methyl] imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 05/14/2003 | EP0941098B1 Method for inhibiting desoxyribonucleotide triphosphate biosynthesis |
| 05/14/2003 | EP0937100B1 A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof |
| 05/14/2003 | EP0934313B1 N-substituted azaheterocyclic compounds |
| 05/14/2003 | EP0932609B1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO 2,3-e]INDOL-8-ONE |
| 05/14/2003 | EP0915872B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 05/14/2003 | EP0915869B1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase |
| 05/14/2003 | EP0873330B1 Diarylalkenylamine derivatives |
| 05/14/2003 | EP0830369B1 Nor-pregnanes for inducing hypothalamic effects |
| 05/14/2003 | EP0800383B1 Pharmaceutical compositions comprising proliposome powders for inhalation |
| 05/14/2003 | EP0797427B1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| 05/14/2003 | EP0794788B1 Hepatic-directed compounds and reagents for preparation thereof |
| 05/14/2003 | EP0794783B1 Cyclodextrins as suspending agents for pharmaceutical suspensions |
| 05/14/2003 | EP0769945B1 Use of 2-phenyl-3-aroylbenzothiophene derivatives for the manufacture of a medicament for bone healing and fracture repair |
| 05/14/2003 | EP0749308B1 Film coated tablet of paracetamol and domperidone |
| 05/14/2003 | EP0667772B1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 05/14/2003 | EP0666929B1 Method of inhibiting replication of hyperproliferative cells |
| 05/14/2003 | CN1418256A Beta glucans from filamentous fungi |
| 05/14/2003 | CN1418255A Herpes virus strains for gene therapy |
| 05/14/2003 | CN1418254A Method for remodelling cell wall polysaccharide structures in plants |
| 05/14/2003 | CN1418224A TCF responsive element |
| 05/14/2003 | CN1418219A Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the prepararation of the derivatives |
| 05/14/2003 | CN1418217A Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof |
| 05/14/2003 | CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound |
| 05/14/2003 | CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity |
| 05/14/2003 | CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents |
| 05/14/2003 | CN1418213A Crgstalline form II of cabergoline |
| 05/14/2003 | CN1418211A 苯并咪唑衍生物 Benzimidazole derivatives |
| 05/14/2003 | CN1418210A Carbocyclik side chain containing, N-substituted Metalloprotease inhibitors |
| 05/14/2003 | CN1418209A Carbocyclic side chain containing metalloprotease inhibitors |
| 05/14/2003 | CN1418207A Agents correcting gene expression regulatory error |
| 05/14/2003 | CN1418206A Method for preparation of 5-cyano-1 (4-fluorophenyl) -1, 3-dihydroisobenzofurans |
| 05/14/2003 | CN1418205A method for preparation of citalopram |
| 05/14/2003 | CN1418203A Percyquinnin, Process for its production and its use pharmaceutical |
| 05/14/2003 | CN1418199A Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors |
| 05/14/2003 | CN1418198A Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl)amino] pyrimidin-5-yl]-(3R5S)-3,5-dihydroxyhept-6-enojc acid |
| 05/14/2003 | CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 05/14/2003 | CN1418196A Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 05/14/2003 | CN1418195A Therapeutic morpholino-substituted compounds |
| 05/14/2003 | CN1418193A heterocyclic side chain containing metalloprotease inbibitors |
| 05/14/2003 | CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/14/2003 | CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
| 05/14/2003 | CN1418190A N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them |
| 05/14/2003 | CN1418188A Method for oxidizing thioether group into sulfoxide group |
| 05/14/2003 | CN1418187A Carboxylic acid derivatives as IP antagonists |
| 05/14/2003 | CN1418186A Novel crystal of stilbene derivative and process for producing the same |
| 05/14/2003 | CN1418185A Aniline-derived ligands for thyroid receptor |
| 05/14/2003 | CN1418121A Compound with 5-HT1A activity useful for treating disorders of outer retina |
| 05/14/2003 | CN1418113A medicinal aerosol formulation |
| 05/14/2003 | CN1418112A Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 05/14/2003 | CN1418111A Novel Ligands and method for preparing same |
| 05/14/2003 | CN1418110A Remedies for sjoegrens syndrome |
| 05/14/2003 | CN1418109A Drugs for complications of diabetes and neuropathy and utilization thereof |
| 05/14/2003 | CN1418108A Parenteral use of bacterial phage associated lysing enzymes for therapeutic treatment of bacterial infections |
| 05/14/2003 | CN1418104A Cosmetic use of hop and ornithine |
| 05/14/2003 | CN1418103A Polysaccharidic esters of N-derivatives of glutamic acid |
| 05/14/2003 | CN1418102A 激素替代疗法 Hormone replacement therapy |
| 05/14/2003 | CN1418101A Method of increasing alertness by administration of vomeropherin and vomeropherin-emitting alarm device |
| 05/14/2003 | CN1418100A Compounds with 5-HT activity useful for controlling visual field loss |
| 05/14/2003 | CN1418099A Choice compound for treatment of fibromyalgia and chronic fatigue syndrome |
| 05/14/2003 | CN1418098A Tamper-resistant oral opioid agonist formulations |
| 05/14/2003 | CN1418097A Oxazolidinone toble formulation |
| 05/14/2003 | CN1418096A IL-8 receptor antagonists |
| 05/14/2003 | CN1418095A Ocular growth and nicotinic antagonists |
| 05/14/2003 | CN1418094A Use of deramciclane for treatment of anxiety and depression |
| 05/14/2003 | CN1418091A Pharmaceutical preparations |
| 05/14/2003 | CN1418090A Process for preparation of accelerated release formulations using compressed fluids |
| 05/14/2003 | CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors |
| 05/14/2003 | CN1418087A Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light |
| 05/14/2003 | CN1418083A Use of plant extracts and sugars to protect keratinous tissue |
| 05/14/2003 | CN1418079A Container for linezolid intravenous solution |
| 05/14/2003 | CN1417326A Latent-energy regeneration cell |
| 05/14/2003 | CN1417218A Kaempferol derivative and its medicinal use |
| 05/14/2003 | CN1417209A Tetrahydroquinoline ketopiperidine compounds and their prepn and use |
| 05/14/2003 | CN1417208A Prepn and application in preparing cancer-treating medicine of mistletoe alkaloid |
| 05/14/2003 | CN1417206A Alkyl sulfonamide phenyl alkylamide compound and its prepn and medicinal use |
| 05/14/2003 | CN1417198A Diterpene compound and its prepn and use |
| 05/14/2003 | CN1417197A Diterpene compound and its prepn and use |
| 05/14/2003 | CN1416918A Medicine conveyance through conformal film |
| 05/14/2003 | CN1416903A Genetic medicine for treating cancer and other diseases characterized by run-off cell division and its prepn process |
| 05/14/2003 | CN1416901A Compound oral prepn for treating pyloric spirobacterium infection |
| 05/14/2003 | CN1416887A Ointment painted to nasal cavity for preventing cold and influenza and its prepn |
| 05/14/2003 | CN1416881A Medicine composition for treating depression and its prepn |
| 05/14/2003 | CN1416868A Medicine for treating urinary calculus |
| 05/14/2003 | CN1416818A Application of aloe polysaccharide in medicine for treating chronic gastroduodenal ulcer |
| 05/14/2003 | CN1416817A Breviscapine dispersing tablet and its prepn |
| 05/14/2003 | CN1416816A Antineoplastic effect and medicine prepn of dioscin |
| 05/14/2003 | CN1416815A Compound prepn containing prostaglandin E1, prostaglandin A1 and prostaglandin B1 and its prepn process and use |
| 05/14/2003 | CN1416814A Medicine prepn for injection and its prepn process |
| 05/14/2003 | CN1416813A Application of matrine oxide in preparing medicine for treating nephrotic syndrome hemorrhagic fevor |
| 05/14/2003 | CN1416812A Liver-targeting mitomycin magnetic nano particle and its prepn and application in medicine |
| 05/14/2003 | CN1416811A Indomethacin liposome eye drops |
| 05/14/2003 | CN1416810A Taxol microemulsion as one new anticarcinogen prepn |
| 05/14/2003 | CN1108308C Gymnema sylvestre extractive, its preparation method and application |
| 05/14/2003 | CN1108307C New saponin compound and its preparation method and application |
| 05/14/2003 | CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed |
| 05/14/2003 | CN1108300C Thiochrome ketones as antifungal agent |
| 05/14/2003 | CN1108299C Method for extracting and separating natural vitamin E from soybeam deodorized material by supercritical CO2 |
| 05/14/2003 | CN1108297C Viformyl cumarins compound, process for preparing same and pharmaceutical composition contg. same |